COL1A2
Collagen alpha-2(I) chain
Also known as: CO1A2_HUMAN, OI4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08123
- Gene
- COL1A2
- Ensembl
- ENSG00000164692
- Chromosome
- 7
- Canonical length
- 1366 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
Canonical amino-acid sequenceUniProt
1366 residues, UniProt reviewed canonical sequence.
>P08123|COL1A2
1 MLSFVDTRTL LLLAVTLCLA TCQSLQEETV RKGPAGDRGP RGERGPPGPP GRDGEDGPTG
61 PPGPPGPPGP PGLGGNFAAQ YDGKGVGLGP GPMGLMGPRG PPGAAGAPGP QGFQGPAGEP
121 GEPGQTGPAG ARGPAGPPGK AGEDGHPGKP GRPGERGVVG PQGARGFPGT PGLPGFKGIR
181 GHNGLDGLKG QPGAPGVKGE PGAPGENGTP GQTGARGLPG ERGRVGAPGP AGARGSDGSV
241 GPVGPAGPIG SAGPPGFPGA PGPKGEIGAV GNAGPAGPAG PRGEVGLPGL SGPVGPPGNP
301 GANGLTGAKG AAGLPGVAGA PGLPGPRGIP GPVGAAGATG ARGLVGEPGP AGSKGESGNK
361 GEPGSAGPQG PPGPSGEEGK RGPNGEAGSA GPPGPPGLRG SPGSRGLPGA DGRAGVMGPP
421 GSRGASGPAG VRGPNGDAGR PGEPGLMGPR GLPGSPGNIG PAGKEGPVGL PGIDGRPGPI
481 GPAGARGEPG NIGFPGPKGP TGDPGKNGDK GHAGLAGARG APGPDGNNGA QGPPGPQGVQ
541 GGKGEQGPPG PPGFQGLPGP SGPAGEVGKP GERGLHGEFG LPGPAGPRGE RGPPGESGAA
601 GPTGPIGSRG PSGPPGPDGN KGEPGVVGAV GTAGPSGPSG LPGERGAAGI PGGKGEKGEP
661 GLRGEIGNPG RDGARGAPGA VGAPGPAGAT GDRGEAGAAG PAGPAGPRGS PGERGEVGPA
721 GPNGFAGPAG AAGQPGAKGE RGAKGPKGEN GVVGPTGPVG AAGPAGPNGP PGPAGSRGDG
781 GPPGMTGFPG AAGRTGPPGP SGISGPPGPP GPAGKEGLRG PRGDQGPVGR TGEVGAVGPP
841 GFAGEKGPSG EAGTAGPPGT PGPQGLLGAP GILGLPGSRG ERGLPGVAGA VGEPGPLGIA
901 GPPGARGPPG AVGSPGVNGA PGEAGRDGNP GNDGPPGRDG QPGHKGERGY PGNIGPVGAA
961 GAPGPHGPVG PAGKHGNRGE TGPSGPVGPA GAVGPRGPSG PQGIRGDKGE PGEKGPRGLP
1021 GLKGHNGLQG LPGIAGHHGD QGAPGSVGPA GPRGPAGPSG PAGKDGRTGH PGTVGPAGIR
1081 GPQGHQGPAG PPGPPGPPGP PGVSGGGYDF GYDGDFYRAD QPRSAPSLRP KDYEVDATLK
1141 SLNNQIETLL TPEGSRKNPA RTCRDLRLSH PEWSSGYYWI DPNQGCTMDA IKVYCDFSTG
1201 ETCIRAQPEN IPAKNWYRSS KDKKHVWLGE TINAGSQFEY NVEGVTSKEM ATQLAFMRLL
1261 ANYASQNITY HCKNSIAYMD EETGNLKKAV ILQGSNDVEL VAEGNSRFTY TVLVDGCSKK
1321 TNEWGKTIIE YKTNKPSRLP FLDIAPLDIG GADQEFFVDI GPVCFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COL1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 1,633 nTPM
Expression across tissuesHPA
Tissue
- cervix: 1,633 nTPM
- ovary: 1,333 nTPM
- smooth muscle: 1,269 nTPM
- gallbladder: 1,250 nTPM
- urinary bladder: 723 nTPM
- placenta: 578 nTPM
Single-cell type
- hepatic stellate cells: 4,422 nCPM
- fibroblasts: 1,711 nCPM
- leydig cells: 1,450 nCPM
- sertoli cells: 781 nCPM
- endometrial stromal cells: 741 nCPM
- peritubular myoid cells: 729 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 30 nTPM
- cerebral cortex: 28 nTPM
- thalamus: 25 nTPM
- basal ganglia: 11 nTPM
- spinal cord: 11 nTPM
- medulla oblongata: 10 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COL1A2.
Disease | AllUniProt
Conditions COL1A2 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, arthrochalasia type, 2 (EDSARTH2) MIM:617821
- Osteogenesis imperfecta 1 (OI1) MIM:166200
- Osteogenesis imperfecta 2 (OI2) MIM:166210
- Ehlers-Danlos syndrome, cardiac valvular type (EDSCV) MIM:225320
- Osteogenesis imperfecta 3 (OI3) MIM:259420
- Osteogenesis imperfecta 4 (OI4) MIM:166220
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 (OIEDS2) MIM:619120
Disease | GeneticClinVar
739 pathogenic / likely-pathogenic of 2,779 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Osteogenesis imperfecta type I
- Ehlers-Danlos syndrome, classic type, 1
- Osteogenesis imperfecta with normal sclerae, dominant form
- Osteogenesis imperfecta, perinatal lethal
- Osteogenesis imperfecta
Disease | ImmuneIEDB
Conditions an epitope on COL1A2 was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.15
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel development
- bone mineralization
- cellular response to amino acid stimulus
- collagen fibril organization
- collagen metabolic process
- extracellular matrix assembly
- odontogenesis
- regulation of blood pressure
- Rho protein signal transduction
- skeletal system development
- skin morphogenesis
- transforming growth factor beta receptor signaling pathway
- protein heterotrimerization
Molecular functions
- extracellular matrix structural constituent
- extracellular matrix structural constituent conferring tensile strength
- identical protein binding
- metal ion binding
- platelet-derived growth factor binding
- protease binding
- protein-macromolecule adaptor activity
- SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COL1A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COL1A2 as an antibody target. Whether an autoantibody or antibody against COL1A2 could matter depends on whether native COL1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COL1A2 is annotated as secreted, so native COL1A2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label COL1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...